Skip to Main Content

Editor’s note: A recording of the conversation is embedded below.

Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma, and health tech leaders. This week, STAT senior medicine writer and editorial director of events Matthew Herper and STAT general assignment reporter Kate Sheridan sit down to discuss the second edition of her report “Ranking biotech’s top venture capital firms.”  They will explore which venture capital funds performed best during the pandemic, and of course be taking your questions live.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Create a display name to comment

This name will appear with your comment